AIRLINK 184.71 Increased By ▲ 0.85 (0.46%)
BOP 12.12 Increased By ▲ 0.30 (2.54%)
CNERGY 7.50 Decreased By ▼ -0.02 (-0.27%)
FCCL 47.52 Increased By ▲ 1.14 (2.46%)
FFL 16.15 No Change ▼ 0.00 (0%)
FLYNG 28.51 Increased By ▲ 0.73 (2.63%)
HUBC 141.58 Increased By ▲ 6.49 (4.8%)
HUMNL 13.18 Increased By ▲ 0.12 (0.92%)
KEL 4.63 Increased By ▲ 0.01 (0.22%)
KOSM 6.31 Increased By ▲ 0.11 (1.77%)
MLCF 60.37 Increased By ▲ 1.20 (2.03%)
OGDC 225.48 Increased By ▲ 2.42 (1.08%)
PACE 6.07 Increased By ▲ 0.28 (4.84%)
PAEL 48.14 Increased By ▲ 3.19 (7.1%)
PIAHCLA 18.27 Increased By ▲ 0.61 (3.45%)
PIBTL 11.05 Increased By ▲ 0.39 (3.66%)
POWER 11.83 Increased By ▲ 0.10 (0.85%)
PPL 189.65 Increased By ▲ 2.60 (1.39%)
PRL 36.36 Increased By ▲ 0.09 (0.25%)
PTC 24.52 Decreased By ▼ -0.25 (-1.01%)
SEARL 102.92 Increased By ▲ 1.97 (1.95%)
SILK 1.15 No Change ▼ 0.00 (0%)
SSGC 36.73 Decreased By ▼ -0.23 (-0.62%)
SYM 15.71 Increased By ▲ 0.02 (0.13%)
TELE 8.11 Increased By ▲ 0.23 (2.92%)
TPLP 11.26 Increased By ▲ 0.43 (3.97%)
TRG 70.31 Increased By ▲ 3.69 (5.54%)
WAVESAPP 11.16 Increased By ▲ 0.34 (3.14%)
WTL 1.40 Increased By ▲ 0.07 (5.26%)
YOUW 3.78 Decreased By ▼ -0.03 (-0.79%)
AIRLINK 184.71 Increased By ▲ 0.85 (0.46%)
BOP 12.12 Increased By ▲ 0.30 (2.54%)
CNERGY 7.50 Decreased By ▼ -0.02 (-0.27%)
FCCL 47.52 Increased By ▲ 1.14 (2.46%)
FFL 16.15 No Change ▼ 0.00 (0%)
FLYNG 28.51 Increased By ▲ 0.73 (2.63%)
HUBC 141.58 Increased By ▲ 6.49 (4.8%)
HUMNL 13.18 Increased By ▲ 0.12 (0.92%)
KEL 4.63 Increased By ▲ 0.01 (0.22%)
KOSM 6.31 Increased By ▲ 0.11 (1.77%)
MLCF 60.37 Increased By ▲ 1.20 (2.03%)
OGDC 225.48 Increased By ▲ 2.42 (1.08%)
PACE 6.07 Increased By ▲ 0.28 (4.84%)
PAEL 48.14 Increased By ▲ 3.19 (7.1%)
PIAHCLA 18.27 Increased By ▲ 0.61 (3.45%)
PIBTL 11.05 Increased By ▲ 0.39 (3.66%)
POWER 11.83 Increased By ▲ 0.10 (0.85%)
PPL 189.65 Increased By ▲ 2.60 (1.39%)
PRL 36.36 Increased By ▲ 0.09 (0.25%)
PTC 24.52 Decreased By ▼ -0.25 (-1.01%)
SEARL 102.92 Increased By ▲ 1.97 (1.95%)
SILK 1.15 No Change ▼ 0.00 (0%)
SSGC 36.73 Decreased By ▼ -0.23 (-0.62%)
SYM 15.71 Increased By ▲ 0.02 (0.13%)
TELE 8.11 Increased By ▲ 0.23 (2.92%)
TPLP 11.26 Increased By ▲ 0.43 (3.97%)
TRG 70.31 Increased By ▲ 3.69 (5.54%)
WAVESAPP 11.16 Increased By ▲ 0.34 (3.14%)
WTL 1.40 Increased By ▲ 0.07 (5.26%)
YOUW 3.78 Decreased By ▼ -0.03 (-0.79%)
BR100 12,602 Increased By 143.7 (1.15%)
BR30 39,293 Increased By 986 (2.57%)
KSE100 117,974 Increased By 972.9 (0.83%)
KSE30 36,496 Increased By 361.4 (1%)
World

Australia administers first Covid-19 vaccines

  • The country's vaccination programme is starting months after other nations', following its provisional approval of the Pfizer product for use in January.
Published February 21, 2021

SYDNEY: Australia's Covid-19 vaccine rollout began Sunday, with top officials among a small group receiving the first jabs a day before the vaccination programme starts in earnest.

Prime Minister Scott Morrison was injected with the Pfizer/BioNTech vaccine at a medical centre in Sydney's northwest, in what the government said was an effort to boost public confidence in the vaccinations.

Jane Malysiak, an aged care resident and WWII survivor in her 80s, was the country's first person to receive the vaccine, followed by health care workers and other officials. "She's taking part in what is a very historic day for our country," Morrison said.

"Tomorrow our vaccination programme starts, so as a curtain-raiser today we're here making some very important points -- that it's safe, that it's important, and we need to start with those who are most vulnerable and are on the front line."

It comes a day after anti-vaccination demonstrations in major cities attracted thousands, with police arresting several protesters in Melbourne, according to public broadcaster ABC.

Almost 22 percent of Australians said they were unlikely to get the jab, with vaccine hesitancy rising in recent months, an Australian National University survey found.

The country's vaccination programme is starting months after other nations', following its provisional approval of the Pfizer product for use in January.

The Oxford/AstraZeneca vaccine was also approved in recent days but is yet to be administered.

Australia has been relatively successful in containing the virus to date, with almost 29,000 cases and 909 deaths in a population of 25 million.

Comments

Comments are closed.